Israel Discount Bank of New York’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-11,193
Closed -$322K – 86
2023
Q4
$322K Sell
11,193
-244
-2% -$7.38K 0.25% 74
2023
Q3
$379K Sell
11,437
-43
-0.4% -$1.52K 0.32% 67
2023
Q2
$421K Sell
11,480
-2,001
-15% -$77.9K 0.34% 65
2023
Q1
$550K Sell
13,481
-744
-5% -$32.1K 0.41% 54
2022
Q4
$729K Sell
14,225
-1,504
-10% -$72.1K 0.62% 38
2022
Q3
$688K Buy
15,729
+911
+6% +$44.3K 0.57% 38
2022
Q2
$777K Buy
14,818
+1,150
+8% +$58.6K 0.59% 35
2022
Q1
$707K Sell
13,668
-735
-5% -$38.1K 0.46% 49
2021
Q4
$851K Sell
14,403
-1,115
-7% -$55.2K 0.53% 41
2021
Q3
$668K Buy
+15,518
New +$687K 0.45% 51
2021
Q1
$540K Sell
14,920
-1,714
-10% -$60.9K 0.42% 57
2020
Q4
$612K Sell
16,634
-5,167
-24% -$190K 0.45% 53
2020
Q3
$759K Sell
21,801
-2,474
-10% -$86.7K 0.49% 49
2020
Q2
$753K Sell
24,275
-4,143
-15% -$141K 0.51% 46
2020
Q1
$880K Buy
28,418
+2,724
+11% +$92.8K 0.68% 43
2019
Q4
$955K Buy
25,694
+722
+3% +$25.7K 0.63% 45
2019
Q3
$852K Buy
24,972
+2,764
+12% +$101K 0.63% 45
2019
Q2
$912K Buy
22,208
+2,424
+12% +$96.3K 0.69% 33
2019
Q1
$797K Buy
19,784
+5,299
+37% +$212K 0.54% 37
2018
Q4
$599K Buy
14,485
+137
+1% +$5.69K 0.46% 40
2018
Q3
$600K Buy
14,348
+100
+0.7% +$3.85K 0.39% 55
2018
Q2
$490K Sell
14,248
-13
-0.1% -$444 0.32% 65
2018
Q1
$480K Buy
14,261
+203
+1% +$6.98K 0.32% 64
2017
Q4
$483K Buy
14,058
+11,004
+360% +$375K 0.33% 63
2017
Q3
$103K Buy
+3,054
New +$98.2K 0.08% 117
2017
Q2
– Sell
-3,373
Closed -$109K – 437
2017
Q1
$109K Sell
3,373
-17,354
-84% -$547K 0.09% 111
2016
Q4
$639K Buy
+20,727
New +$633K 0.58% 36

Other funds holding PFE

Israel Discount Bank of New York's PFE Position: Q1 2024 in Review

Israel Discount Bank of New York sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,193 shares — an estimated $322K sold.

Israel Discount Bank of New York first reported a position in PFE in Q4 2016 and held it in 27 quarters. The position peaked at $955K in Q4 2019. 2,884 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Israel Discount Bank of New York reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Israel Discount Bank of New York sold 11,193 Pfizer shares in Q1 2024, an estimated $322K.
  • Israel Discount Bank of New York first reported a position in Pfizer in Q4 2016 and held it in 27 quarters.
  • Israel Discount Bank of New York's Pfizer position peaked at $955K in Q4 2019.
  • 2,884 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Israel Discount Bank of New York's 13F filing for Q1 2024, filed 7 May 2024.